
Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study
Cohen, Stanley B, Alonso-Ruiz, Alberto, Klimiuk, Piotr A, Lee, Eric C, Peter, Nuala, Sonderegger, Ivo, Assudani, DeepakLangue:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2017-212245
Date:
March, 2018
Fichier:
PDF, 848 KB
english, 2018